General Information of the Compound
Compound ID
CP0085839
Compound Name
[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone
    Show/Hide
Synonyms
((4aR)-1-(4-fluorophenyl)-6-(1-methyl-1H-pyrazole-4-sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone
1496510-51-0
2158753C7E
AKOS032945759
CORT-125134
CORT125134
J3.651.009I
Methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoqui
Relacorilant
Relacorilant [INN]
Relacorilant [USAN:INN]
Relacorilant [WHO-DD]
SCHEMBL15454999
UNII-2158753C7E
WANIDIGFXJFFEL-SANMLTNESA-N
ZINC141949519
relacorilant
    Show/Hide
Structure
Formula
C27H22F4N6O3S
Molecular Weight
586.571
Canonical SMILES
Cn1cc(cn1)S(=O)(=O)N1CCC2=Cc3c(C[C@@]2(C1)C(=O)c1cc(ccn1)C(F)(F)F)cnn3-c1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1
    Show/Hide
InChIKey
WANIDIGFXJFFEL-SANMLTNESA-N
CAS
1496510-51-0
Physicochemical Property
logP
4.0621
Rotatable Bonds
5
Heavy Atom Count
41
Polar Areas
102.98
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
8
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 73051463
ChEMBL ID
CHEMBL4068611
DrugBank ID
DB14976
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
Ki = 7.2 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CORT-125134 )
Drug Name CORT-125134
Company Corcept TherapeuticsMenlo Park, CA
Indication
Cushing disease
Phase 3
Solid tumour/cancer
Phase 1/2
Alcohol dependence
Clinical trial
Target(s)
Glucocorticoid receptor (NR3C1)
Antagonist